Cite
Efficacy and safety analysis of rituximab combined with chemotherapy in the treatment of B-cell lymphoma patients complicated with hepatitis B virus infection.
MLA
S., Wang, et al. “Efficacy and Safety Analysis of Rituximab Combined with Chemotherapy in the Treatment of B-Cell Lymphoma Patients Complicated with Hepatitis B Virus Infection.” Indian Journal of Cancer, vol. 53, no. 3, July 2016, pp. 443–47. EBSCOhost, https://doi.org/10.4103/0019-509X.200679.
APA
S., W., Z., Z., H., C., Y., W., Wang, S., Zhang, Z., Cai, H., & Wang, Y. (2016). Efficacy and safety analysis of rituximab combined with chemotherapy in the treatment of B-cell lymphoma patients complicated with hepatitis B virus infection. Indian Journal of Cancer, 53(3), 443–447. https://doi.org/10.4103/0019-509X.200679
Chicago
S., Wang, Zhang Z., Cai H., Wang Y., S Wang, Z Zhang, H Cai, and Y Wang. 2016. “Efficacy and Safety Analysis of Rituximab Combined with Chemotherapy in the Treatment of B-Cell Lymphoma Patients Complicated with Hepatitis B Virus Infection.” Indian Journal of Cancer 53 (3): 443–47. doi:10.4103/0019-509X.200679.